Advanced search
Publication Cover
Leukemia & Lymphoma Volume 51, 2010 - Issue 12
Submit an article Journal homepage
583
Views
18
CrossRef citations to date
0
Altmetric
Reviews

Molecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myeloma

Sham Mailankody
,
Esther MenaMolecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
,
Constance M. YuanFlow Cytometry Unit, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
,
Arun BalakumaranNational Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA
,
W. Michael KuehlGenetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
&
Ola LandgrenMedical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USACorrespondence[email protected]
Pages 2159-2170 | Received 30 Jul 2010, Accepted 17 Sep 2010, Published online: 20 Oct 2010

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Sham Mailankody, Sean M. Devlin, Neha Korde, Nikoletta Lendvai, Alexander Lesokhin, Heather Landau, Hani Hassoun, Andrea Ballagi, Daniel Ekman, David J. Chung, Minal Patel, Guenther Koehne, Sergio Giralt & Ola Landgren. (2017) Proteomic profiling in plasma cell disorders: a feasibility study. Leukemia & Lymphoma 58:7, pages 1757-1759.
Read now
Yannick Lecluse, Elisabeth Comby, Delphine Mariotte, Séverine Tual, Brigitte Le Mauff, Pierre Lebailly & Pascal Gauduchon. (2016) Prevalence of monoclonal gammopathy of undetermined significance (MGUS) among farmers involved in open field farming and/or cattle breading in France. Leukemia & Lymphoma 57:7, pages 1727-1730.
Read now
Sigurdur Y Kristinsson, Alex R Minter, Neha Korde, Esther Tan & Ola Landgren. (2011) Bone disease in multiple myeloma and precursor disease: novel diagnostic approaches and implications on clinical management. Expert Review of Molecular Diagnostics 11:6, pages 593-603.
Read now

Articles from other publishers (15)

Timothy Schmidt & Natalie S. Callander. (2023) EXABS-121-MM MGUS/SMM: Incidence, Evaluation and Follow-up. Clinical Lymphoma Myeloma and Leukemia 23, pages S26-S30.
Crossref
Bénedith Oben, Charlotte Cosemans, Ellen Geerdens, Loes Linsen, Kimberly Vanhees, Brigitte Maes, Koen Theunissen, Bert Cruys, Marta Lionetti, Ingrid Arijs, Niccolò Bolli, Guy Froyen & Jean-Luc Rummens. (2022) The Dynamics of Nucleotide Variants in the Progression from Low–Intermediate Myeloma Precursor Conditions to Multiple Myeloma: Studying Serial Samples with a Targeted Sequencing Approach. Cancers 14:4, pages 1035.
Crossref
Timothy M. Schmidt & Natalie S. Callander. (2020) Diagnosis and Management of Monoclonal Gammopathy and Smoldering Multiple Myeloma. Journal of the National Comprehensive Cancer Network 18:12, pages 1720-1729.
Crossref
Bénedith ObenCharlotte CosemansIngrid ArijsLoes LinsenAnnick DaniëlsJeroen DeclercqBrigitte MaesKimberly VanheesGuy FroyenJean-Luc Rummens. (2019) Archival May-Grünwald–Giemsa-Stained Bone Marrow Smears Are an Eligible Source for Molecular DNA Research. Biopreservation and Biobanking 17:4, pages 274-281.
Crossref
Charlotte Cosemans, Bénedith Oben, Ingrid Arijs, Annick Daniëls, Jeroen Declercq, Kimberly Vanhees, Guy Froyen, Brigitte Maes, Jeroen Mebis & Jean-Luc Rummens. (2018) Prognostic Biomarkers in the Progression From MGUS to Multiple Myeloma: A Systematic Review. Clinical Lymphoma Myeloma and Leukemia 18:4, pages 235-248.
Crossref
Athanasios Papadas & Fotis Asimakopoulos. 2018. Mechanisms of Drug Resistance in Cancer Therapy. Mechanisms of Drug Resistance in Cancer Therapy 251 288 .
Sham Mailankody & Ola Landgren. (2016) Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemia. Best Practice & Research Clinical Haematology 29:2, pages 187-193.
Crossref
Carmen Quiñones‐Torrelo, María Pilar Villanueva‐Gil, Ana Rodríguez‐Muñoz, Lidia Abellán‐Tejada, Manuel Aparici‐Ibáñez & Arturo Carratalá‐Calvo. (2014) When an Analytical Interference Is a Useful Diagnostic Tool: Finding Monoclonal Gammopathies in Routine Analysis. Journal of Clinical Laboratory Analysis 30:2, pages 140-144.
Crossref
Vanessa Szablewski, Céline René & Valérie Costes. (2015) Indolent cytotoxic T cell lymphoproliferation associated with nodular regenerative hyperplasia: a common liver lesion in the context of common variable immunodeficiency disorder. Virchows Archiv 467:6, pages 733-740.
Crossref
Sham Mailankody, Neha Korde, Alexander M. Lesokhin, Nikoletta Lendvai, Hani Hassoun, Maryalice Stetler-Stevenson & Ola Landgren. (2015) Minimal residual disease in multiple myeloma: bringing the bench to the bedside. Nature Reviews Clinical Oncology 12:5, pages 286-295.
Crossref
S Vincent Rajkumar, Meletios A Dimopoulos, Antonio Palumbo, Joan Blade, Giampaolo Merlini, María-Victoria Mateos, Shaji Kumar, Jens Hillengass, Efstathios Kastritis, Paul Richardson, Ola Landgren, Bruno Paiva, Angela Dispenzieri, Brendan Weiss, Xavier LeLeu, Sonja Zweegman, Sagar Lonial, Laura Rosinol, Elena Zamagni, Sundar Jagannath, Orhan Sezer, Sigurdur Y Kristinsson, Jo Caers, Saad Z Usmani, Juan José Lahuerta, Hans Erik Johnsen, Meral Beksac, Michele Cavo, Hartmut Goldschmidt, Evangelos Terpos, Robert A Kyle, Kenneth C Anderson, Brian G M Durie & Jesus F San Miguel. (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. The Lancet Oncology 15:12, pages e538-e548.
Crossref
Debmalya Barh, Angelo Carpi, Mukesh Verma & Mehmet GunduzMichael Byrne, Joseph Katz & Jan Moreb. 2014. Cancer Biomarkers. Cancer Biomarkers 871 908 .
Christiaan Righolt & Sabine Mai. (2012) Shattered and stitched chromosomes—chromothripsis and chromoanasynthesis—manifestations of a new chromosome crisis?. Genes, Chromosomes and Cancer 51:11, pages 975-981.
Crossref
Neha Korde, Sigurdur Y. Kristinsson & Ola Landgren. (2011) Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies. Blood 117:21, pages 5573-5581.
Crossref
Ola Landgren. (2011) Multiple Myeloma Precursor Disease: Current Clinical Dilemma and Future Opportunities. Seminars in Hematology 48:1, pages 1-3.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.